close
Add to watchlist
Insulet Corp (PODD)
Insulet Corporation, a medical device company, engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes in the United States. The company offers OmniPod Insulin Management System (OmniPod System), an insulin infusion system that provides a pain-free automated cannula insertion. It consists of OmniPod disposable insulin infusion device and handheld wireless personal diabetes manager; and provides people with a diabetes management solution that offers lifestyle and other benefits. Insulet Corporation has an agreement with Ferring Pharmaceuticals to develop the OmniPod System for the delivery of a Ferring drug. It serves healthcare professionals, people with insulin-dependent diabetes, and third-party payors. The company sells the OmniPod System directly to patients through referrals from healthcare professionals and through patient leads. Insulet Corporation was founded in 2000 and is headquartered in Bedford, Massachusetts.
(login to add this stock to your watchlist or favorites)
Key Statistics
| Closing Price | 19.47 |
| Volume | 205784 |
| Volume Avg | 353918 |
| 52 Week High | 23.33 |
| 52 Week Low | 14.00 |
| PE | N/A |
| PE (group average) | N/A |
| EPS Year | -1.22 |
| EPS change Q/Q | -56% |
| EPS change Q/Q Yr ago | -42.11% |
| EPS change Q/Q next Q est | -12% |
| EPS change Y/Y | -55.8% |
| REV change Q/Q | 1.8% |
| REV change Q/Q Yr ago | 36.06% |
| EPS next Q est | -0.25 |
| EPS next Y est | -0.17 |
| Divident Annual | 0.00 |
| Dividend Yield | 0% |